GERAP's Epidemiological Survey on Perioperative Hypersensitivity Reactions

University Hospital, Strasbourg, France3,000 enrolled

Overview

Perioperative hypersensitivity reactions are still associated with significant morbidity and mortality despite early recognition and use of epinephrine. The epidemiology of these reactions evolves over time and changes with clinical practice. The main objective is to study the epidemiology of these reactions over a 10-year period, including patient phenotype, reaction phenotype and outcome of the allergic work-up.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Hypersensitivity, Drug

Eligibility

Sex: ALLMin age: 7 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Minor and major subject * Subject having experienced a perioperative hypersensitivity reaction between January the 1st 2017 and December the 31st 2027. * Referred for an allegro-anesthetic workup * Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research. Exclusion Criteria: * Subject having expressed opposition to participating in the study * Inability to provide the subject with research information * Subject under guardianship or guardianship * Subject under safeguard of justice

Locations (1)

Service d'anesthésie-réanimation - CHU de Strasbourg - France

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Retrospective analysis of incidence of all perioperative hypersensitivity reactions referred in an allegro-anesthetic

Time frame: Outcome is analysed every 2 years over a 10 years period

Central Contacts

Paul-Michel MERTES, MD, PhD

CONTACT

33 3 69 55 04 44 paul-michel.mertes@chru-strasbourg.fr

Charles TACQUARD, MD

CONTACT

33.3.69.55.16.08 charlesambroise.tacquard@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.